av/neumora-therapeutics--big.svg

COM:NEUMORATX

Neumora Therapeutics, Inc.

  • Stock

USD

Last Close

9.69

22/11 21:00

Market Cap

1.72B

Beta: -

Volume Today

490.17K

Avg: -

  • name

    Neumora Therapeutics, Inc. Common Stock
  • homepage url

    www.neumoratx.com
  • country

    USUnited States
  • linkedin url

    neumora
  • crunchbase url

    neumora-therapeutics
  • employee count

    120
  • sector

    Healthcare
  • industry

    Biotechnology
  • monthly webtraffic

    6.75K
  • monthly webtraffic growth

    16.55%
  • stage

    Series B
  • raised capital

    112M

Description

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disord...Show More

peer of

investor of

competitor of